95582-17-5 (2-甲基-5-(甲氨基)吡嗪,(S)-3-Cbz-amino-2-piperidone)

CAS号:
95582-17-5
中文名称:
2-甲基-5-(甲氨基)吡嗪
英文名称:
(S)-3-Cbz-amino-2-piperidone
分子式:
C13H16N2O3
分子量:
248.277743339539

2-甲基-5-(甲氨基)吡嗪(95582-17-5)名称与标识符

名称

中文别名:
(S)-3-(Cbz-氨基)-2-哌啶酮;(S)-3-cbz-氨基-2-哌啶酮;2-甲基-5-(甲氨基)吡嗪;[(3S)-2-氧代-3-哌啶基]氨基甲酸苄酯;
英文别名:
(S)-3-(Cbz-amino)-2-piperidone;(S)?-?3-?Cbz-?Aminopiperidin-?2-?one;(S)-3-CBZ-AMINO-2-PIPERIDONE;benzyl N-[(3S)-2-oxopiperidin-3-yl]carbamate;Carbamic acid,[(3S)-2-oxo-3-piperidinyl]-, phenylmethyl ester (9CI);(S)-3-N-Cbz-Aminopiperidin-2-one;(S)-3-Benzyloxycarbonylamino-2-piperidone;Benzyl (S)-2-oxopiperidin-3-ylcarbamate;(S)-Benzyl (2-oxopiperidin-3-yl)carbamate;(S)-benzyl 2-oxopiperidin-3-ylcarbamate;Carbamic acid, [(3S)-2-oxo-3-piperidinyl]-, phenylmethyl ester;(S)-Nenzyl (2-oxopiperidin-3-yl)carbamate;KVHNKJHAXXEKFU-NSHDSACASA-N;6528AJ;FCH3601537;AB43572;(S)-3-benzy;Carbamic acid, (2-oxo-3-piperidinyl)-, phenylmethyl ester, (S)- (ZCI);Carbamic acid, [(3S)-2-oxo-3-piperidinyl]-, phenylmethyl ester (9CI);(3S)-3-Benzyloxycarbonylamino-2-piperidinone;95582-17-5;A845337;W-205548;MFCD08166408;AKOS015918106;VDA58217;DTXSID40467310;EN300-6735227;SCHEMBL4078569;benzyl N-[(3S)-2-oxo-3-piperidyl]carbamate;(phenylmethyl) N-[(3S)-2-oxidanylidenepiperidin-3-yl]carbamate;AS-37240;(3S)-3-benzyloxycarbonylamino-2-piperidone;Benzyl(S)-2-oxopiperidin-3-ylcarbamate 95%;Benzyl [(3S)-2-oxopiperidin-3-yl]carbamate;N-[(3S)-2-oxo-3-piperidinyl]carbamic acid (phenylmethyl) ester;(S)-3-Cbz-aminopiperidin-2-one;(S)-(2-OXO-PIPERIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER;

标识符

MDL:
MFCD08166408
InChIKey:
KVHNKJHAXXEKFU-NSHDSACASA-N
Inchi:
1S/C13H16N2O3/c16-12-11(7-4-8-14-12)15-13(17)18-9-10-5-2-1-3-6-10/h1-3,5-6,11H,4,7-9H2,(H,14,16)(H,15,17)/t11-/m0/s1
SMILES:
N([C@H]1CCCNC1=O)C(=O)OCC1C=CC=CC=1

2-甲基-5-(甲氨基)吡嗪(95582-17-5)物化性质

实验特性

  • LogP : 1.91110
  • PSA : 67.43000
  • 沸点 : 502.5℃at760mmHg
  • 熔点 : 101-102 ºC
  • 溶解度 : 微溶 (1.1 g/L) (25 ºC),
  • 颜色与性状 : White to Yellow Solid
  • 密度 : 1.22±0.1 g/cm3 (20 ºC 760 Torr),

计算特性

  • 精确分子量 : 248.11600
  • 氢键供体数量 : 2
  • 氢键受体数量 : 3
  • 可旋转化学键数量 : 4
  • 同位素质量 : 248.11609238g/mol
  • 重原子数量 : 18
  • 复杂度 : 301
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 1
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.3
  • 拓扑分子极性表面积 : 67.4

2-甲基-5-(甲氨基)吡嗪(95582-17-5)安全信息

2-甲基-5-(甲氨基)吡嗪(95582-17-5)海关数据

海关编码:
2933790090
海关数据:

中国海关编码:

2933790090

概述:

2933790090 其他内酰胺. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:9.0% 普通关税:20.0%

申报要素:

品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期

Summary:

2933790090. other lactams. VAT:17.0%. Tax rebate rate:9.0%. . MFN tariff:9.0%. General tariff:20.0%

2-甲基-5-(甲氨基)吡嗪(95582-17-5)推荐厂家 更多厂家(8)

2-甲基-5-(甲氨基)吡嗪(95582-17-5)合成路线

合成路线:1 步
反应条件:
参考文献:
Rapid and Mild Lactamization Using Highly Electrophilic Triphosgene in a Microflow Reactor
Fuse, Shinichiro ; Komuro, Keiji ; Otake, Yuma ; Masui, Hisashi ; Nakamura, Hiroyuki, Chemistry - A European Journal, 2021, 27(27), 7525-7532
合成路线:1 步
反应条件:
参考文献:
Preparation of tripeptoid analogs as serine protease inhibitors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of heterocyclic compounds as serine protease inhibitors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of N-substituted prolinyl peptide analogs as serine protease inhibitors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of prolinyl peptide analogs as serine protease inhibitors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of fused cycloheptane azole heterocyclic peptoids as serine protease inhibitors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of N-substituted derivatives of azole heterocyclic peptoids as serine protease inhibitors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of azole heterocyclic peptoids containing keto or diketo ring systems as serine protease inhibitors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of azole heterocyclic peptoids as serine protease inhibitors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
preparation of proline analog peptides as serine protease inhibitors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of oxadiazole peptide analogs as serine protease inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of optically-active octahydropyrrolo[3,2-b]pyridin-2-one derivatives and their intermediates
, Japan, , ,
合成路线:1 步
反应条件:
参考文献:
First synthesis and determination of the absolute configuration of sulphostin, a novel inhibitor of dipeptidyl peptidase IV
Abe, Masatoshi; Akiyama, Tetsuo; Nakamura, Hikaru; Kojima, Fukiko; Harada, Shigeko; et al, Journal of Natural Products, 2004, 67(6), 999-1004
合成路线:1 步
反应条件:
参考文献:
Development of a Large-Scale Synthesis of Sulphostin, a Dipeptidyl Peptidase IV Inhibitor
Abe, Masatoshi; Nagai, Masashi; Yamamoto, Keiichiro; Yamazaki, Hiroko; Koga, Ichiro; et al, Organic Process Research & Development, 2005, 9(5), 570-576
合成路线:1 步
反应条件:
参考文献:
Preparation of azacycloalkanone serine protease inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Synthesis of L-[5-11C]ornithine
Ding, Yu Shin; Antoni, Gunnar; Fowler, Joanna S.; Wolf, Alfred P.; Langstrom, Bengt, Journal of Labelled Compounds and Radiopharmaceuticals, 1989, 27(9), 1079-90
合成路线:1 步
反应条件:
参考文献:
Preparation of sulfonamide lactams as Factor Xa inhibitors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of arylsulfonamidopiperidones as inhibitors of Factor Xa.
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of backbone-cyclized peptide derivatives as serine protease and thrombin inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Phosphonamide-substituted lactams
, Federal Republic of Germany, , ,

2-甲基-5-(甲氨基)吡嗪(95582-17-5)上下游